http://www.acc.org/Feed?clinicalTopicID=0cff9a6b-fc84-483b-890b-4b2da15dc2d5 Clinical Topic Feed: Angiography en /Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/FFR-in-Focus Two studies recently published in JACC: Cardiovascular Interventions provide fresh insights into coronary physiology, suggesting that angiography-derived fractional flow reserve (FFR) may be a practical alternative to wire-based FFR, while highlighting the prognostic significance of definite discordance between FFR and nonhyperemic pressure ratios (NHPR). 1786468140000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/01/01/JACC-in-a-Flash Featured topics and Editors' Picks from all of ACC's JACC Journals. 1782907800000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/16/16/01/eagles-eye-view-17jun2026 In this week’s View, Dr. Eagle highlights a study showing race and sex disparities in M-TEER outcomes, with Black patients presenting with more advanced disease, lower success, and higher heart failure readmissions than White patients, and women having lower success rates than men. 1781701440000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/08/17/44/Follow-Up-of-FAVOR-III When compared with angiography guidance, quantitative flow ratio (QFR)-guided PCI improved five-year clinical outcomes with benefits primarily achieved in the first two years, according to a follow-up study of the multicenter, sham-controlled FAVOR III trial published June 10 in JACC. 1781194140000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/03/13/24/eagles-eye-view-03jun2026 In this week’s View, Dr. Eagle looks at recent research found in ACC’s new expert decision pathway for postpartum cardiovascular care. He then offers insights from the ACC Chest Pain - MI Registry examining ‘low risk’ chest pain and its evaluation in the emergency departments. 1780493220000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Cover-Story-Tricuspid-Valve-Intervention For decades, cardiologists have referred to the tricuspid valve as "the forgotten valve." One reason for this neglect is that tricuspid regurgitation (TR) often goes unnoticed, explains Robert O. Bonow, MD, MACC, Distinguished Professor at Northwestern University Feinberg School of Medicine in Chicago, IL. 1780316340000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/05/26/10/02/Rise-in-Deferral In the evaluation of patients with low-risk chest pain, there has been a rise in the deferral of further testing, with lower rates of functional testing and invasive coronary angiography (ICA), and significant variation at the site level in the proportion of patients who underwent further noninvasive testing... 1779801480000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/mon-1045am-combo-acc-2026 When compared with angiography-guided PCI, IVUS-guided PCI was found to be not superior in patients with complex coronary arteries according to results from the IVUS-CHIP trial or in patients with unprotected left main coronary artery disease (LM-CAD) according to results from the OPTIMAL trial. Both trials were presented in a Late-Breaking Clinical Trial session at ACC.26 in New Orleans. 1774885860000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/mon-1045am-dkcrush-acc-2026 When using the two-stent double-kissing (DK) crush technique for PCI to treat complex coronary artery bifurcation lesions, IVUS-guided PCI was associated with a greater reduction in target vessel failure compared to angiography-guided PCI, according to the DKCRUSH VIII trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in JACC. 1774885560000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-allrise-acc-2026 FFRangio, a minimally invasive, artificial intelligence (AI)-assisted, novel method of measuring fractional flow reserve (FFR), performed similarly to traditional wire-based testing in patients with coronary artery disease (CAD) undergoing assessment for PCI, according to results from the ALL-RISE trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in NEJM. 1774791240000 Articles and Stories